{"id":"W4400144366","doi":"10.1016/j.annonc.2024.05.019","title":"8MO Neoadjuvant botensilimab (BOT) plus balstilimab (BAL) in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Sanofi Genzyme; Genentech; Foundation Medicine; Sierra Oncology; INCLIVA Instituto de Investigación Sanitaria; European Society for Medical Oncology; PharmaMar; Daiichi Sankyo Europe; Gilead Sciences; Servier; FibroGen; Astellas Pharma; Eisai; Natera; F-star Therapeutics; Ribon Therapeutics; Ipsen; Sociedad Española de Oncología Médica; BeiGene; Clovis Oncology; Merck KGaA; Sanofi; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004753176,0.0008541568,0.001341812,0.0001879393,0.0002706561,0.0006604613,0.0003211483,0.000900393,0.004567148],"category_scores_gemma":[0.0004343147,0.0003284487,0.001254826,0.0001858173,0.0005591601,0.0006804944,0.0003131106,0.002217092,0.0009979308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005290812,"about_ca_system_score_gemma":0.0006989118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004586313,"about_ca_topic_score_gemma":0.001801458,"domain_scores_codex":[0.9998253,0.00005551422,0.00001013515,0.00003483313,0.00001367995,0.00006054838],"domain_scores_gemma":[0.9997759,0.00003195521,0.00003700656,0.00001974237,0.00001164188,0.0001236794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.844173,0.01267828,0.003500867,0.001306483,0.001559716,0.0001910631,0.0001139572,0.001980514,0.01762653,0.0004849385,0.004668884,0.1117157],"study_design_scores_gemma":[0.6156078,0.3563646,0.01240896,0.0002384921,0.001530387,0.0003230501,0.0001049213,0.001621981,0.003470093,0.0006812061,0.007594607,0.00005394802],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892232,0.00484617,0.0004111704,0.00108394,0.0004745179,0.0005903007,0.0006070154,0.00009928163,0.002664376],"genre_scores_gemma":[0.9845931,0.003619208,0.0009201778,0.001639024,0.0002871822,0.001570955,0.001439788,0.00002735326,0.005903159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004567148,"threshold_uncertainty_score":0.01527864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1642273022822641,"score_gpt":0.4733978749761782,"score_spread":0.3091705726939141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}